Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18565886 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Intervention: Biological: bevacizumab

Indicates status has not been verified in more than two years